HomeANAB • NASDAQ
add
AnaptysBio Inc
Previous close
$17.71
Day range
$16.79 - $18.08
Year range
$12.21 - $41.31
Market cap
512.42M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 43.11M | 378.77% |
Operating expense | 10.19M | -0.80% |
Net income | -21.78M | 48.39% |
Net profit margin | -50.53 | 89.22% |
Earnings per share | -0.72 | 54.72% |
EBITDA | -9.52M | 72.50% |
Effective tax rate | 0.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 385.37M | -1.41% |
Total assets | 483.83M | 6.95% |
Total liabilities | 412.97M | 13.36% |
Total equity | 70.87M | — |
Shares outstanding | 30.67M | — |
Price to book | 7.60 | — |
Return on assets | -4.95% | — |
Return on capital | -5.42% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -21.78M | 48.39% |
Cash from operations | -66.67M | -94.10% |
Cash from investing | -29.40M | -159.77% |
Cash from financing | 27.57M | 634.35% |
Net change in cash | -68.50M | -808.39% |
Free cash flow | -34.83M | -81.76% |
About
Founded
2005
Headquarters
Website
Employees
136